12/01/2021 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$26.76 |
Details |
Payment from |
Biohaven Pharmaceuticals, Inc. |
Payment Record ID |
852396229 |
|
07/29/2021 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$8.15 |
Details |
Payment from |
AstraZeneca Pharmaceuticals LP |
Payment Record ID |
834350111 |
|
10/21/2021 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$14.77 |
Details |
Payment from |
AstraZeneca Pharmaceuticals LP |
Payment Record ID |
834341069 |
|
09/29/2021 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$119.05 |
Details |
Payment from |
AstraZeneca Pharmaceuticals LP |
Payment Record ID |
834324445 |
|
03/22/2021 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$11.49 |
Details |
Payment from |
Lilly USA, LLC |
Payment Record ID |
818919865 |
|
09/29/2021 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$17.43 |
Details |
Payment from |
Novo Nordisk Inc |
Payment Record ID |
811014051 |
|
07/22/2021 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$23.10 |
Details |
Payment from |
Novo Nordisk Inc |
Payment Record ID |
810822575 |
|
09/08/2021 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$14.45 |
Details |
Payment from |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Payment Record ID |
763569034 |
|
10/21/2020 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$10.97 |
Details |
Payment from |
Abbott Laboratories |
Payment Record ID |
749023067 |
|
04/02/2020 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$17.58 |
Details |
Payment from |
Gilead Sciences, Inc. |
Payment Record ID |
747949889 |
|
06/18/2020 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$13.04 |
Details |
Payment from |
Merck Sharp & Dohme Corporation |
Payment Record ID |
747702175 |
|
11/21/2020 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$14.12 |
Details |
Payment from |
Novo Nordisk Inc |
Payment Record ID |
744998421 |
|
09/10/2020 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$15.81 |
Details |
Payment from |
Novo Nordisk Inc |
Payment Record ID |
744872001 |
|
01/30/2020 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$16.96 |
Details |
Payment from |
Amarin Pharma Inc. |
Payment Record ID |
739759607 |
|
06/10/2020 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$14.28 |
Details |
Payment from |
Salix Pharmaceuticals, a division of Bausch Health US, LLC |
Payment Record ID |
737479773 |
|
06/15/2020 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$22.62 |
Details |
Payment from |
Lilly USA, LLC |
Payment Record ID |
728311319 |
|
10/28/2020 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$19.08 |
Details |
Payment from |
Boston Scientific Corporation |
Payment Record ID |
725554643 |
|
09/10/2019 |
Research |
In-kind items and services |
|
$30.86 |
Details |
Payment from |
GlaxoSmithKline, LLC. |
Paymment Research Study |
A PHASE 3 STUDY TO COMPARE THE EFFICACY AND SAFETY OF GEPOTIDACIN WITH |
Payment Record ID |
709082751 |
|
09/10/2019 |
Research |
In-kind items and services |
|
$213.14 |
Details |
Payment from |
GlaxoSmithKline, LLC. |
Paymment Research Study |
A PHASE 3 STUDY TO COMPARE THE EFFICACY AND SAFETY OF GEPOTIDACIN WITH |
Payment Record ID |
709081463 |
|
08/27/2019 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$11.52 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Payment Record ID |
694139315 |
|
07/18/2019 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$11.73 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Payment Record ID |
694111177 |
|
10/24/2019 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$19.23 |
Details |
Payment from |
OptiNose US, Inc. |
Payment Record ID |
684269861 |
|
06/26/2019 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$19.08 |
Details |
Payment from |
OptiNose US, Inc. |
Payment Record ID |
684269803 |
|
07/16/2019 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$14.30 |
Details |
Payment from |
Lilly USA, LLC |
Payment Record ID |
657649051 |
|
04/05/2019 |
Research |
In-kind items and services |
Drug |
$36.06 |
Details |
Payment from |
AbbVie, Inc. |
Paymment Research Study |
M16-100 |
Payment Record ID |
647627735 |
|
04/05/2019 |
Research |
In-kind items and services |
Drug |
$58.57 |
Details |
Payment from |
AbbVie, Inc. |
Paymment Research Study |
M16-100 |
Payment Record ID |
647627733 |
|
04/05/2019 |
Research |
In-kind items and services |
Drug |
$487.02 |
Details |
Payment from |
AbbVie, Inc. |
Paymment Research Study |
M16-100 |
Payment Record ID |
647627731 |
|
04/05/2019 |
Research |
In-kind items and services |
Drug |
$18.86 |
Details |
Payment from |
AbbVie, Inc. |
Paymment Research Study |
M16-100 |
Payment Record ID |
647627729 |
|
04/05/2019 |
Research |
In-kind items and services |
Drug |
$18.75 |
Details |
Payment from |
AbbVie, Inc. |
Paymment Research Study |
M16-100 |
Payment Record ID |
647627727 |
|
04/04/2019 |
Research |
In-kind items and services |
Drug |
$204.06 |
Details |
Payment from |
AbbVie, Inc. |
Paymment Research Study |
M16-100 |
Payment Record ID |
647627725 |
|
05/03/2019 |
Research |
In-kind items and services |
Drug |
$38.69 |
Details |
Payment from |
AbbVie, Inc. |
Paymment Research Study |
M16-100 |
Payment Record ID |
647627723 |
|
09/29/2018 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$55.95 |
Details |
Payment from |
Allergan Inc. |
Payment Record ID |
596145929 |
|
09/29/2018 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$56.46 |
Details |
Payment from |
Allergan Inc. |
Payment Record ID |
596145924 |
|
09/29/2018 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$27.22 |
Details |
Payment from |
Allergan Inc. |
Payment Record ID |
596145913 |
|
09/29/2018 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$370.41 |
Details |
Payment from |
Allergan Inc. |
Payment Record ID |
596145903 |
|
09/29/2018 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$190.87 |
Details |
Payment from |
Allergan Inc. |
Payment Record ID |
596145893 |
|
09/27/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$43.79 |
Details |
Payment from |
Allergan Inc. |
Payment Record ID |
596145883 |
|
09/27/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$19.21 |
Details |
Payment from |
Allergan Inc. |
Payment Record ID |
596145877 |
|
09/27/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$50.00 |
Details |
Payment from |
Allergan Inc. |
Payment Record ID |
596145868 |
|
09/27/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$144.36 |
Details |
Payment from |
Allergan Inc. |
Payment Record ID |
596145859 |
|
09/27/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$18.34 |
Details |
Payment from |
Allergan Inc. |
Payment Record ID |
596145851 |
|
09/27/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$74.62 |
Details |
Payment from |
Allergan Inc. |
Payment Record ID |
596145843 |
|
07/26/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$10.52 |
Details |
Payment from |
Lilly USA, LLC |
Payment Record ID |
559163273 |
|
12/10/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$11.17 |
Details |
Payment from |
Lilly USA, LLC |
Payment Record ID |
559163271 |
|
01/20/2017 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$577.75 |
Details |
Payment from |
Novo Nordisk AS |
Payment Record ID |
468291951 |
|
01/20/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$403.75 |
Details |
Payment from |
Novo Nordisk AS |
Payment Record ID |
468291949 |
|
01/20/2017 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$202.09 |
Details |
Payment from |
Novo Nordisk AS |
Payment Record ID |
468291947 |
|
01/20/2017 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$121.18 |
Details |
Payment from |
Novo Nordisk AS |
Payment Record ID |
468290473 |
|
04/25/2017 |
Research |
Cash or cash equivalent |
|
$125.00 |
Details |
Payment from |
Allergan Inc. |
Paymment Research Study |
A MULTICENTER, RANDOMIZED, OPEN LABEL EXTENSION STUDY TO EVALUATE THE LONG TERM SAFETY AND TOLOERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRANE WITH R WITHOUT AURA |
Payment Record ID |
463956687 |
|
04/25/2017 |
Research |
Cash or cash equivalent |
|
$175.00 |
Details |
Payment from |
Allergan Inc. |
Paymment Research Study |
A MULTICENTER, RANDOMIZED, OPEN LABEL EXTENSION STUDY TO EVALUATE THE LONG TERM SAFETY AND TOLOERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRANE WITH R WITHOUT AURA |
Payment Record ID |
463956683 |
|
03/16/2017 |
Research |
Cash or cash equivalent |
|
$125.00 |
Details |
Payment from |
Allergan Inc. |
Paymment Research Study |
A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SINGLE ATTACK STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRAINE |
Payment Record ID |
463956679 |
|
03/16/2017 |
Research |
Cash or cash equivalent |
|
$175.00 |
Details |
Payment from |
Allergan Inc. |
Paymment Research Study |
A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SINGLE ATTACK STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRAINE |
Payment Record ID |
463956677 |
|
02/02/2017 |
Research |
Cash or cash equivalent |
|
$700.00 |
Details |
Payment from |
Allergan Inc. |
Paymment Research Study |
A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SINGLE ATTACK STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRAINE |
Payment Record ID |
463956672 |
|
02/02/2017 |
Research |
Cash or cash equivalent |
|
$500.00 |
Details |
Payment from |
Allergan Inc. |
Paymment Research Study |
A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SINGLE ATTACK STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRAINE |
Payment Record ID |
463956667 |
|
02/02/2017 |
Research |
Cash or cash equivalent |
|
$175.00 |
Details |
Payment from |
Allergan Inc. |
Paymment Research Study |
A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SINGLE ATTACK STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRAINE |
Payment Record ID |
463956661 |
|
02/02/2017 |
Research |
Cash or cash equivalent |
|
$125.00 |
Details |
Payment from |
Allergan Inc. |
Paymment Research Study |
A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SINGLE ATTACK STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRAINE |
Payment Record ID |
463956657 |
|
01/31/2017 |
Research |
Cash or cash equivalent |
|
$356.00 |
Details |
Payment from |
Allergan Inc. |
Paymment Research Study |
A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SINGLE ATTACK STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRAINE |
Payment Record ID |
463956653 |
|
01/24/2017 |
Research |
Cash or cash equivalent |
|
$356.00 |
Details |
Payment from |
Allergan Inc. |
Paymment Research Study |
A MULTICENTER, RANDOMIZED, OPEN LABEL EXTENSION STUDY TO EVALUATE THE LONG TERM SAFETY AND TOLOERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRANE WITH R WITHOUT AURA |
Payment Record ID |
463956649 |
|
01/10/2017 |
Research |
Cash or cash equivalent |
|
$620.00 |
Details |
Payment from |
Allergan Inc. |
Paymment Research Study |
A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SINGLE ATTACK STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRAINE |
Payment Record ID |
463956645 |
|
01/05/2017 |
Research |
Cash or cash equivalent |
|
$175.00 |
Details |
Payment from |
Allergan Inc. |
Paymment Research Study |
A MULTICENTER, RANDOMIZED, OPEN LABEL EXTENSION STUDY TO EVALUATE THE LONG TERM SAFETY AND TOLOERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRANE WITH R WITHOUT AURA |
Payment Record ID |
463956641 |
|
01/05/2017 |
Research |
Cash or cash equivalent |
|
$125.00 |
Details |
Payment from |
Allergan Inc. |
Paymment Research Study |
A MULTICENTER, RANDOMIZED, OPEN LABEL EXTENSION STUDY TO EVALUATE THE LONG TERM SAFETY AND TOLOERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRANE WITH R WITHOUT AURA |
Payment Record ID |
463956637 |
|
01/05/2017 |
Research |
Cash or cash equivalent |
|
$620.00 |
Details |
Payment from |
Allergan Inc. |
Paymment Research Study |
A MULTICENTER, RANDOMIZED, OPEN LABEL EXTENSION STUDY TO EVALUATE THE LONG TERM SAFETY AND TOLOERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRANE WITH R WITHOUT AURA |
Payment Record ID |
463956631 |
|
10/06/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$12.65 |
Details |
Payment from |
Lilly USA, LLC |
Payment Record ID |
457116781 |
|
08/25/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$23.77 |
Details |
Payment from |
Abbott Laboratories |
Payment Record ID |
452875427 |
|
09/14/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$24.99 |
Details |
Payment from |
Abbott Laboratories |
Payment Record ID |
452869137 |
|
10/12/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$10.87 |
Details |
Payment from |
AstraZeneca Pharmaceuticals LP |
Payment Record ID |
445108499 |
|
09/10/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$572.50 |
Details |
Payment from |
Novo Nordisk AS |
Payment Record ID |
392189792 |
|
09/08/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$181.75 |
Details |
Payment from |
Novo Nordisk AS |
Payment Record ID |
391914148 |
|
09/08/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$373.34 |
Details |
Payment from |
Novo Nordisk AS |
Payment Record ID |
391914138 |
|
09/08/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$1038.44 |
Details |
Payment from |
Novo Nordisk AS |
Payment Record ID |
391914128 |
|
11/21/2016 |
General (Non-Research) |
Cash or cash equivalent |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$165.43 |
Details |
Payment from |
Otonomy, Inc. |
Payment Record ID |
386948722 |
|
10/14/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$41.77 |
Details |
Payment from |
AstraZeneca AB |
Payment Record ID |
363478762 |
|
10/14/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$55.34 |
Details |
Payment from |
AstraZeneca AB |
Payment Record ID |
363231844 |
|
10/14/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$23.88 |
Details |
Payment from |
AstraZeneca AB |
Payment Record ID |
363172778 |
|
10/13/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$94.79 |
Details |
Payment from |
AstraZeneca AB |
Payment Record ID |
363066616 |
|
10/13/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$287.60 |
Details |
Payment from |
AstraZeneca AB |
Payment Record ID |
362920508 |
|
10/14/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$68.52 |
Details |
Payment from |
AstraZeneca AB |
Payment Record ID |
362890376 |
|
10/13/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$1670.20 |
Details |
Payment from |
AstraZeneca AB |
Payment Record ID |
362403074 |
|